CL
AUPH icon

CSS LLC’s Aurinia Pharmaceuticals AUPH Stock Holding History

CSS LLC’s Portfolio AUPH Stock Details AUPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-27,338
Closed -$206K – 951
2022
Q3 		$206K Sell
27,338
-7,200
-21% -$62.3K 0.01% 745
2022
Q2 		$347K Hold
34,538
– – 0.01% 672
2022
Q1 		$428K Buy
34,538
+19,180
+125% +$296K 0.02% 653
2021
Q4 		$351K Sell
15,358
-39,875
-72% -$945K 0.01% 766
2021
Q3 		$1.22M Buy
55,233
+25,100
+83% +$398K 0.05% 367
2021
Q2 		$391K Sell
30,133
-1,487
-5% -$18.9K 0.02% 692
2021
Q1 		$411K Sell
31,620
-13,221
-29% -$192K 0.02% 626
2020
Q4 		$620K Buy
44,841
+833
+2% +$12.1K 0.02% 416
2020
Q3 		$648K Sell
44,008
-6,450
-13% -$93.4K 0.03% 373
2020
Q2 		$820K Buy
50,458
+32,333
+178% +$518K 0.05% 305
2020
Q1 		$263K Buy
18,125
+17,903
+8,064% +$316K 0.02% 388
2019
Q4 		$4K Buy
+222
New +$2.04K ﹤0.01% 639

Other funds holding AUPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

CSS LLC's AUPH Position: Q4 2022 in Review

CSS LLC sold out of Aurinia Pharmaceuticals (AUPH) in Q4 2022, closing a stake of 27,338 shares — an estimated $206K sold.

CSS LLC first reported a position in AUPH in Q4 2019 and held it in 12 quarters. The position peaked at $1.22M in Q3 2021. 191 funds tracked by Wall St. Rank hold AUPH as of Q4 2022.

  • CSS LLC reported no remaining Aurinia Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • CSS LLC sold 27,338 Aurinia Pharmaceuticals shares in Q4 2022, an estimated $206K.
  • CSS LLC first reported a position in Aurinia Pharmaceuticals in Q4 2019 and held it in 12 quarters.
  • CSS LLC's Aurinia Pharmaceuticals position peaked at $1.22M in Q3 2021.
  • 191 funds tracked by Wall St. Rank held Aurinia Pharmaceuticals as of Q4 2022.

Based on CSS LLC's 13F filing for Q4 2022, filed 14 Feb 2023.